![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Echo Therapeutics Announces First Quarter 2011 Financial Results
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive,...
ELC Group announces doubled revenues
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation announced today a total revenue increase of...
GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March...
GlaxoSmithKline Pharmaceuticals profit grows by 16%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March...
Impax Laboratories Reports First Quarter 2011 Financial Results
Impax Laboratories, Inc.reported first quarter ended March 31, 2011 financial results. Larry Hsu, Ph.D., president...
IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4...
The IMS Institute for Healthcare Informatics today reported a 2.3 percent increase in spending on...
Novo Nordisk increased operating profit by 27% in 2010
Organic sales growth of 19% driven by Victoza®, NovoRapid® and Levemir® Sales increased by 19%...
Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
Pfizer Inc.reported financial results for fourth-quarter and full-year 2010. Since the acquisition of Wyeth was...
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies,...
Genzyme Financial Recovery Continues in Fourth Quarter
Genzyme Corp. reported that preliminary fourth-quarter revenue grew 23 percent to $1.15 billion from $938...